Stap Tab Tablet
NDC Package 43742-2015-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Stap Tab (staphylococcus aureus, klebsiella pneumoniae, enterococcus faecalis, pneumococcinum, streptococcus agalactiae, streptococcus mutans, haemophilus influenzae b, streptococcus viridans) tablets is for temporary relief of symptoms related to upper respiratory infections including fever, cough and runny nose.****These statements are based upon homeopathic principles. This formulation utilizes a tablet delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-2015.

Identification & Billing

NDC Package Code
43742-2015-1
Package Description
90 TABLET in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
43742201501

Clinical Specifications

Proprietary Name
Stap Tab
Non-Proprietary Name
Staphylococcus Aureus, Klebsiella Pneumoniae, Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Mutans, Haemophilus Influenzae B, Streptococcus Viridans
Substance Name
Enterococcus Faecalis; Haemophilus Influenzae Type B; Klebsiella Pneumoniae; Staphylococcus Aureus; Streptococcus Agalactiae; Streptococcus Mutans; Streptococcus Pneumoniae; Streptococcus Viridans Group
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
For temporary relief of symptoms related to upper respiratory infections including fever, cough and runny nose.****These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration. For temporary relief of symptoms related to upper respiratory infections including fever, cough and runny nose.****These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Regulatory & Marketing

Labeler Name
Deseret Biologicals, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
07-29-2021
End Marketing Date
11-30-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43742-2015-1 identifies a specific commercial package of 90 tablet in 1 bottle, plastic of Stap Tab, a human over the counter drug labeled by Deseret Biologicals, Inc.. This tablet is formulated for oral use and contains enterococcus faecalis; haemophilus influenzae type b; klebsiella pneumoniae; staphylococcus aureus; streptococcus agalactiae; streptococcus mutans; streptococcus pneumoniae; streptococcus viridans group as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on July 29, 2021.

How is this Deseret Biologicals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742201501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
43742-2015-1
11-Digit CMS (5-4-2)
43742-2015-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.